CCR5 cell surface density and HIV-1 envelope sequences govern antiretroviral potency of CCR5 antagonists

被引：0
|
作者：
Miller, MD
Lineberger, JE
Dornadula, G
Danzeisen, RC
Blau, CR
Danovich, RM
Miller, MA
Finke, PE
Oates, BD
Caldwell, CG
Chen, P
Meurer, LC
Mills, SG
Springer, MS
Petropoulos, CJ
Whitcomb, J
Huang, W
Fransen, S
Simon, AJ
Hazuda, DJ
机构：
[1] Merck Res Labs, Dept Biol Chem, West Point, PA USA
[2] Merck Res Labs, Dept Microbial Vaccine Res, West Point, PA USA
[3] Dept Med Chem, Rahway, NJ USA
[4] Dept Immunol & Rheumatol, Rahway, NJ USA
[5] ViroLog Inc, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
61
引用
收藏
页码：U66 / U67
页数：2
相关论文
共 50 条
  • [21] CCR5 monoclonal antibodies for HIV-1 therapy
    Olson, William C.
    Jacobson, Jeffrey M.
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (02) : 104 - 111
  • [22] HIV-1 infection and CCR5Δ32 homozygosis
    Ballana, Ester
    Este, Jose A.
    FUTURE VIROLOGY, 2012, 7 (07) : 653 - 658
  • [23] Choosing CCR5 or Rev siRNA in HIV-1
    H. Jose Arteaga
    Jorma Hinkula
    Iris van Dijk-Härd
    M. Sirac Dilber
    Britta Wahren
    Birger Christensson
    Abdalla J. Mohamed
    C. I. Edvard Smith
    Nature Biotechnology, 2003, 21 : 230 - 231
  • [24] CCR5 as target for HIV-1 gene therapy
    Nazari, Reza
    Joshi, Sadhna
    CURRENT GENE THERAPY, 2008, 8 (04) : 264 - 272
  • [25] CCR5 antagonist-resistant HIV-1 entry kinetics as a function of CD4 and CCR5 surface expression
    Putcharoen, O.
    Lee, S-H
    Henrich, T. J.
    Vanichanan, J.
    Kuritzkes, D. R.
    Tsibris, A. M. N.
    ANTIVIRAL THERAPY, 2011, 16 : A64 - A64
  • [26] CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
    Oh, Djin-Ye
    Jessen, Heiko
    Kuecherer, Claudia
    Neumann, Konrad
    Oh, Nari
    Poggensee, Gabriele
    Bartmeyer, Barbara
    Jessen, Arne
    Pruss, Axel
    Schumann, Ralf R.
    Hamouda, Osamah
    PLOS ONE, 2008, 3 (07):
  • [27] Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry
    Nahabedian, John
    Sharma, Amit
    Kaczmarek, Maryska E.
    Wilkerson, Greg K.
    Sawyer, Sara L.
    Overbaugh, Julie
    VIROLOGY, 2017, 512 : 180 - 186
  • [28] CCR5 antagonists as anti-HIV agents
    不详
    DRUG DISCOVERY TODAY, 2001, 6 (14) : 747 - 747
  • [29] CCR5 antagonists as anti-HIV agents
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (09) : 428 - 429
  • [30] CCR5 and HIV infection
    Blanpain, C
    Libert, F
    Vassart, G
    Parmentier, M
    RECEPTORS & CHANNELS, 2002, 8 (01): : 19 - 31
12345